Press Releases AroCell AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 10:56:08 2024-05-14 EDT			5-day change	1st Jan Change
0.418 ^SEK	+1.21%		-3.91%	-4.35%

05-03	AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Swedish Diagnostics Company AroCell Secures US Patent	MT

AroCell AB (publ) Interim Report January 1st to March 31st, 2024	05-06	AQ
AroCell Q1 - Unrecognized and going well	05-06	AQ
AroCell AB (publ) Interim Report January 1st to March 31st, 2024	05-03	AQ
AroCell - New patent approved on the US market	04-19	AQ
New patent approved on the US market	04-18	AQ
AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics	04-16	PU
AroCell publishes the Annual Report for 2023	04-15	AQ
AroCell publishes the Annual Report for 2023	04-12	AQ
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024	03-12	AQ
New Study: UBC Rapid can reduce the number of cystoscopies necessary in bladder cancer patients, enabling cost-effective follow-up	03-12	AQ
Two Accepted Abstracts at AACR 2024 Explore Clinical Applications of TK1 Biomarker	03-11	AQ
AroCell : Presentation at LabRoots 2024	03-04	PU
AroCell Q4 - Nearing positive operating cash flow	02-23	AQ
AroCell AB (publ) Interim Report January 1st to December 31st, 2023	02-22	AQ
Ellen Dittberner, AroCell's CFO, will be taking parental leave, and Lars Jakobsson will step in as the interim CFO.	02-01	AQ
AroCell has obtained regulatory approval for TUBEX TF in Ethiopia	01-26	AQ
AroCell has obtained regulatory approval for TUBEX® TF in Ethiopia	01-25	AQ
AroCell - Serum TK1 protein levels can predict survival of prostate cancer patients	01-16	AQ
Serum TK1 protein levels can predict survival of prostate cancer patients	01-15	AQ
AroCell nomination committee for the AGM 2024	11-16	AQ

No results for this search